These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5341211)

  • 1. [Plasma expander--with reference to dextran and low-molecular weight dextran].
    Momose T
    Iryo; 1967 Jan; 21(1):18-25. PubMed ID: 5341211
    [No Abstract]   [Full Text] [Related]  

  • 2. Dextran; a valuable plasma volume expander.
    LEONSINS AJ
    S Afr Med J; 1952 Jul; 26(27):546-9. PubMed ID: 12984180
    [No Abstract]   [Full Text] [Related]  

  • 3. An assessment of the potential use of anionic dextrans as a plasma substitute.
    Chang RL; Crawford MP; West MD
    J Biomed Eng; 1980 Jan; 2(1):41-4. PubMed ID: 7359897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of dextran; a plasma volume expander; studies of radioactive carbon-labeled dextran in dogs.
    TERRY R; YUILE CL; GOLODETZ A; PHILLIPS CE; WHITE RR
    J Lab Clin Med; 1953 Jul; 42(1):6-15. PubMed ID: 13061827
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the effect of dextran as a plasma volume expander].
    SCHWARTZKOPFF W
    Z Klin Med; 1962; 157():156-66. PubMed ID: 13909747
    [No Abstract]   [Full Text] [Related]  

  • 6. The present status of dextran as a plasma expander.
    HOWARD JM; EBERT RV; BLOOM WL; SLOAN MH
    Am J Surg; 1959 May; 97(5):593-6. PubMed ID: 13650049
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of a new dextran plasma expander.
    DARGAN EL; METCALF W; HEHRE EJ; OHIN A
    JAMA; 1962 Jan; 179():203-6. PubMed ID: 13883542
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of dextran as a plasma volume expander.
    BOWMAN HW
    J Am Med Assoc; 1953 Sep; 153(1):24-6. PubMed ID: 13069263
    [No Abstract]   [Full Text] [Related]  

  • 9. DEXTRAN, plasma volume expander for shock.
    Whats New; 1954; 181():5-8. PubMed ID: 24543004
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma expander and physiological saline in infusion therapy (Dextran; polyvinylpyrrolidone (PVP); I-131-PVP)].
    SCHWARTZKOPFF W; van der HAEGEN K; KOLM H
    Med Welt; 1962 Sep; 36():1891-8. PubMed ID: 13909743
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics of dextran].
    Gruber UF
    Anesth Analg (Paris); 1976; 3(4):505-8. PubMed ID: 1015636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characterization of clinical dextrans by gel chromatography (author's transl)].
    Pitz H
    Anaesthesist; 1975 Nov; 24(11):500-3. PubMed ID: 1211606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextran--plasma volume expanders clinical experiences especially with low molecular weight preparations.
    Arturson G
    Bibl Haematol; 1968; 29():914-26. PubMed ID: 5728135
    [No Abstract]   [Full Text] [Related]  

  • 14. [Death caused by infusion of low-molecular dextran].
    Plamieniak L; Kowal-Gierczak B; Kotschy M; Kurzawska M; Kozlowska B
    Wiad Lek; 1974 May; 27(10):901-5. PubMed ID: 4839858
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on dextran and dextran derivatives. XIV. Metal binding properties of succinyl- and phthalyl-dextrans.
    Bombardieri G; Rotilio G; Crifò C; De Marco C
    Arch Biochem Biophys; 1968 Sep; 127(1):766-9. PubMed ID: 4301571
    [No Abstract]   [Full Text] [Related]  

  • 16. Low molecular weight dextran infusions.
    Ibsen B
    Br Med J; 1971 Apr; 2(5753):109. PubMed ID: 5551261
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of low molecular dextran, its combination with essential amino acids and various plasma expanders--with reference to electric charge of the erythrocyte, hemolysis and the blood stability].
    Aochi O; Goto Y; Yasunaka H; Takeshita S; Nitani Y
    Geka Chiryo; 1967 Mar; 16(3):362-6. PubMed ID: 6072735
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies on dextran and other plasma substitutes].
    MURAWSKI K; KRYSIAK IJ
    Pol Tyg Lek (Wars); 1953 Aug; 8(34):1188-9; contd. PubMed ID: 13120490
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of Pluronic F-68, low molecular weight dextran, mannitol, and saline as priming agents in the heart-lung apparatus. I. Pluronic F-68: first use as a plasma substitute.
    Hymes AC; Safavian MH; Arbulu A; Baute P
    J Thorac Cardiovasc Surg; 1968 Jul; 56(1):16-22. PubMed ID: 5663128
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of blood constituents on brain function during perfusion experiments with the cat brain. I. Brain perfusion with artificial blood containing low molecular weight dextran].
    Morimitsu J
    Seishin Shinkeigaku Zasshi; 1968 Apr; 70(4):330-40. PubMed ID: 5693993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.